IMG_9869.jpeg
M7 TG Logo.png

M7 TecGroup

 

an M7 HillGroup Company

Focus Areas

Energy

Aerospace

Defense

infrastructure

M7TecGroup concentrates on

 

New Product Development

World Class Manufacturing

Value Stream Support

Life Cycle Sustainment

Breakthroughs

  • Development of synthetically designed materials

  • Digitally Engineered Manufactured products

  • Intelligent materials based upon rare earth, inorganic and organic design

 

  • Creating a strong Environmental, Social, and Governance (ESG) ecosystem

IMG_0592.JPG
IMG_8571_edited.jpg

3P Development

&

Collaboration

As of 2019 M7TecGroup embarked on its Strategic Mission at Texas A&M University's RELLIS Facilities.

 

Our Mission is to create innovation and generate value for ourselves and our partner entities via our Private Public Partnership's. We tirelessly strive to create revolutionary technologies and sustainable solutions in order to move our highly attractive and economically  driven  programs.

4B489725-D291-41A9-9CFA-A09044E85124_edi

M7 TecGroup (M7TG), a subsidiary of M7 HillGroup (M7HG), provides a range of products and services to the Department of Defense and Fortune 50 companies, including Lockheed Martin Skunk Works.

In 2019, M7HG launched M7TG, based in College Station, Texas. 

 

M7TG Focus:

  • Research and Development

  • Manufacturing

  • Logistics

 

Industry Sectors

  • Aerospace

  • Defense

  • Energy

  • Infrastructure

  • Medical

 

Our vision is to build a long term Private Public Partnership and ecosystem to produce and export Made in Texas products

Technologies

IMG_9103_edited.jpg

High End Growth

  • Infrastructure Transformation

  • Aerospace Materials

  • Next Generation Medical Solutions

  • Revolutionary Energy Programs

Covid-19 Response

M7 TecGroup is a Founding Member of Strategic Vaccines, LLC.  Strategic Vaccines, LLC designs vaccines and therapeutics to combat viral threats. 

M7TecGroup is collaborating with Lockheed Martin and Texas A&M CIADM to provide high volume production of FLOWVID 20, a T-Cell Therapeutic to defeat COVID-19 in College Station, Texas.